chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At first within three days I became extremely fatigued. I had to take a nap during the day and I would sleep between 2-3 hours. I work in home health and I was able to go to work. I work part time but it was extremely hard for me to work with all the fatigue. That lasted for three weeks and then I developed like cold symptoms. Congestion, cough, light sensitivity and fever on off and the fatigue. I had a cough and it just never went away after the cold symptoms went away that has persisted until this day. I'm oxygen therapy.  So I had a chest CT the first one was 05/28/2021 and they found ground glass opacities.  They found atlectifis. Basically my lungs are scarred like someone who had covid but all my covid test have been negative.  I had to go to the hospital about three weeks ago for extreme shortness of breath. When I'm up walking around without oxygen I was dropping to 84% and my heartrate would go up to 128.  So they sent me home and I'm oxygen when I'm up walking around and when I'm sleeping now. They've also tested me for different things like parasite and bacteria. The only thing that they found was efinophilic pneumonia. I am on 60mg of prednisone daily. My lungs are improving a little bit but  I still need oxygen. I'm being followed my a pomologist right now.
Sore arm, limited range of motion with arm, rotator cuff needing physical therapy.
pt recvd vax; devel urticarial rash all over body; non pruritic; no meds;
Lymph nodes swollen with particularly large lump under left arm that made it uncomfortable to relax my arm at my side. Most swelling lasted about a day but the lump under my arm continues although with no discomfort. I've consulted with a primary care physician and my ob/gyn at my annual check-up. They are not concerned with the plan being to monitor and follow up with primary care.
Moderna 3/1/21, 3/29/21, 10/25/21. Positive on 6/4/22
5 hours after immunization developed head ache and stroke like symptoms with left facial droop, ataxia and left arm and leg weakness. she was given tpa for stroke and transferred to Hospital.
5:15pm Patient complaint of some throat tightness and SOB, his arm is a little sore. Advised to take Zyrtec 10mg and if worsening in respiratory or throat sx to call 911.  6pm parent called stating he is doing better. No throat symptoms, chest aches a bit with deep breaths but no SOB or wheeze. Arm a bit more sore now. Instructed to monitor at home and if any anaphylactic sx to call 911. Advised to get benedryl and give 25mg at HS. Plan to pre-medicate for next HPV vaccine.
Patient received a flu shot at 5:48pm in the pharmacy consult room and went shopping up front with her mother.  Patient fainted in the front store at 5:55pm while waiting in line to cash out.  I helped the patient lie down on the floor, elevated her feet and applied a cool compress to her neck.  At 6:10pm her symptoms had resolved and she was able to walk out of the store with her mother.  I placed a follow up phone call to her mother at 7:10pm and she stated that patient was fully recovered.
SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for covid-19 prophylaxis. No concomitant medications were reported. On AUG-2023, the patient experienced shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of shortness of breath was not reported. This report was non-serious. This report was associated with product quality complaint: 90000294162.
Pt complained of her arm being painful after 2 days after flu vaccine. Administration arm painful when trying to lift over head. Taking ALEVE and applying mineral ice.
Sudden onset red, hot , burning rash near or just below the injection side on the left arm, started February 6, 2021 at approximately 5:00 p.m. Continues on February 7, 2021, possibly a little larger than yesterday. Photo was taken today. Topical treatment of cortisone cream, Benadryl, and lidocaine ointment.
Rec'd telephone call from EE reporting symptoms after receiving her Moderna COVID-19 booster vaccine on 11/29/2021 from facility in the left deltoid. EE states she has swelling under her left armpit and pain that is radiating to her elbow. EE states the pain is getting worse and she can not sleep and can barely lift her left arm. EE stated she would like to be seen by a provider. EE stated she went to the Employee health clinic and was told to call the nurse vaccine support line. Informed EE her symptoms would be documented in OHM, an event report would be done and a case would be opened for her. Informed EE an employee health nurse would contact her regarding the next steps. Advised EE she could take Tylenol or Ibuprofen if not allergic as needed per package instructions for pain, and she could apply cold packs for 15 minutes at a time every 2 hours for pain and swelling. Also advised EE to follow TCH illness in the workplace policy. EE voiced understanding and had no other questions.
Within an hour started feeling weird.  over the course of the next 36 hours, my reaction to the vaccine is awful. Worse than my covid.  At least I know my body is doing what it is supposed to be doing. But it is just miserable. Massive headache, soreness, weird shooting pains in my leg, sweats and chills and nausea, and now the racing heart and shortness of breath.
really bad headache down to jaw and neck; really bad headache down to jaw and neck; chest feels uncomfortable; really bad headache down to jaw and neck; chills; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 06-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (really bad headache down to jaw and neck), NECK PAIN (really bad headache down to jaw and neck), CHEST DISCOMFORT (chest feels uncomfortable), HEADACHE (really bad headache down to jaw and neck) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN JAW (really bad headache down to jaw and neck), NECK PAIN (really bad headache down to jaw and neck), CHEST DISCOMFORT (chest feels uncomfortable), HEADACHE (really bad headache down to jaw and neck), CHILLS (chills) and NAUSEA (nauseous). At the time of the report, PAIN IN JAW (really bad headache down to jaw and neck), NECK PAIN (really bad headache down to jaw and neck), CHEST DISCOMFORT (chest feels uncomfortable), HEADACHE (really bad headache down to jaw and neck), CHILLS (chills) and NAUSEA (nauseous) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
1-2 minutes after shot felt pain in shoulder, into (R) chest then felt flushed, short of breath. No previous reaction to multiple flu shots. No egg allergy.
fever 101 AM 27JAN98 & PM to 105;seen in ER PM 27JAN98 then AM 28JAN98 w/fever w/rash all over body;given ATB of 8hr for unk dx by mom;vomited, diarrhea, clear drainage from nose;coughing;pulling @ lt ear;viral synd;
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 21-OCT-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L018499; expiry: 25-FEB-2017. (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Full body aches, chills, sore injection site. Ibuprofen 600mg taken every 4-6 hours and an epsom salt bath, rest. Symptoms lasted all day and into the following morning.
Pt stated his lip (upper) became swollen the morning after receiving both flu and pneumonia vaccines. Pt took ZYRTEC on own then took BENADRYL later in the day. On 12-16-17, Pt lip has improved some per patient.
IM (R) deltoid - injection of PNEUMOVAX vaccination - Localized edema / no pain/ no systemic symptoms.
This is a literature report. A health-care system experience. The full publication has been requested. This author reported different events for five patients. This is the fourth of five reports.  A subject of unspecified age and gender received bnt162b2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The medical history and concomitant medications were not reported. The subject experienced symptoms consistent with anaphylaxis on an unspecified date with outcome of unknown. The subject underwent lab tests and procedures which included allergy test with unknown results.  Background: Adverse reactions, including anaphylaxis, to messenger RNA coronavirus disease 2019 (COVID-19) vaccines rarely occur. Because of the need to administer a timely second dose in subjects who reported a reaction to their first dose, a panel of health-care professionals developed a safe triage of the employees and health care providers (EHCP) at a large health-care system to consider administration of future dosing. Methods: There were 28,544 EHCPs who received their first dose of COVID-19 vaccines between December 15, 2020, and March 8, 2021. The EHCPs self-reported adverse reactions to a centralized COVID-19 command center (CCC). The CCC screened and collected information on the quality of reaction, symptoms, and timing of the onset of the reaction. Results: Of 1253 calls to the CCC, 113 were identified as requiring consideration by a panel of three (Board of Allergy and Immunology) certified allergists for future dosing or formal in-person assessment. Of the 113 EHCPs, 94 (83.2%) were recommended to get their second dose. Eighty of 94 received their second planned dose without a severe or immediate reaction. Of the 14 of 113 identified as needing further evaluation, 6 were evaluated by a physician and subsequently received their second dose without a serious adverse reaction. Eight of 14 did not receive their second dose. Only 5 of the 113 EHCPs reported reactions (4.4%) were recommended to not take the second dose: 3 (2.6%) because of symptoms consistent with anaphylaxis, and 2 because of neurologic complications (seizure, stroke). Conclusion: The panel demonstrated that, by consideration of reaction history alone, the ECHPs could be appropriately triaged to receive scheduled second dosing of COVID-19 vaccines without delays for in-person evaluation and allergy testing. Sender's Comments: A contributory role of BNT162B2 in triggering the onset of Anaphylaxis cannot be fully excluded, considering the temporal relationship and known adverse event profile of the suspect vaccine, Linked Report(s): US-PFIZER INC-202101300055 Same article/drug/event; Different patient.
Headache; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 26Jan2021 14:45 (Batch/Lot Number: EL9264) as single dose for COVID-19 immunisation. The patient had no medical history. The patient's concomitant medications were not reported. No other vaccine in four weeks. On 27Jan2021 08:00 AM, the patient experienced headache. She took Ibuprofen for headache. No covid prior vaccination and not tested post vaccination. Outcome of the event was recovered.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL. Subsequently the patient fainted after receiving the GARDASIL. The patient had recovered (date unspecified). The patient sought the physician for medical attention. This is one of several reports received from the same source. Additional information has been requested.
After one week of shot being administered, injection site was itchy, hard and hot to the touch. Bright red and swollen.
Info has been received from a health professional concerning a 11 year old healthy female with Down's Syndrome who on 1/17/96 was vaccinated with a dose of varicella virus vaccine live. On 7/3/05, the pt experienced 50 lesions on her back, chest, groin and face described as itchy fluid filled blisters. She was afebrile. Treatment was symptomatic and the pt is recovering. No product quality complaint was involved. Follow-up info has been received which indicated that the pt's condition resolved. Additional info is not expected.
patient complaines of vomiting, headache, chills, runny nose, body aches.
Hives.  Pt c/o one hive on L jawline below ear and "head feels funny". Describes feeling "lightheaded". Recommeded to be medicated with Benadryl 25 mg po, pt refused. Pt is scheduled for annual PE with Dr at 1000  BP: 120/73, P; 62, RR: 16 non-labored, SaO2: 95% on RA. Pt waited 30 minutes and left the vaccine clinic stating she would wait in main hospital lobby until her MD appt at 1000.
Swollen Lymph node under right arm; This is a spontaneous report from a contactable consumer, the patient. An unspecified aged non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 00:00 as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 29Apr2021, the patient had swollen lymph node under right arm a week later where the injection was given. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of event swollen lymph node under right arm was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient received vaccine 2 weeks earlier than manufacturer recommendation. Denied any significant symptoms, but reported "sniffles and congestion." The symptoms may or may not be related to vaccine administration.
Pt. states that after receiving the 1st dose of Phizer 11/18/2021, started experiencing symptoms 11/21/2021 of soreness in the (left) arm, redness in the left side of the face and neck (dryness). Allergist communications 11/21/2021 recommended over-the-counter Antihistamines and prescribed Hydrocortisone. Symptoms have subsided with dryness of the left side of face and neck.
Delivered baby girl 2/5/21. Breastfeeding and pumping at time of both vaccines. Shortly After second vaccine I developed mastitis, completed a course of antibiotics and have enlarged lymph node in the right breast which is still under continued ultrasound surveillance
vaccine was expired on 20 Mar 2022 and it was stored in refrigerator on 31 Mar 2022; We have some Moderna Covid-19 vaccine that expired on 20Mar2022 that we gave a few doses of.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that expired on 20Mar2022 that we gave a few doses of.) and PRODUCT STORAGE ERROR (vaccine was expired on 20 Mar 2022 and it was stored in refrigerator on 31 Mar 2022) in a 90-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that expired on 20Mar2022 that we gave a few doses of.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was expired on 20 Mar 2022 and it was stored in refrigerator on 31 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that expired on 20Mar2022 that we gave a few doses of.) and PRODUCT STORAGE ERROR (vaccine was expired on 20 Mar 2022 and it was stored in refrigerator on 31 Mar 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.  Dose was administered after 30-day Use By Date or after manufacturer date of expiry. 8 doses were given from the expired vials. Initially vial was stored in refrigerator on 31 Mar 2022  Vial did not undergo any temperature excursion.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2022: Follow up received contains no new information.
The pt experienced a fever, severe muscle and joint aches, nausea, decreased appetite, abdominal pain, neck and back pain.
large local reaction right deltoid region, 5 x 7 cm, otherwise no symptoms.
Case number PHEH2014US024331, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with follow-up from a nurse received on 19 Jan 2015. This report refers to an 11 years old female patient. Her medical history and concomitant medications were not reported. She had tolerated vaccines (no further details provided) well in the past. She was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 05 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received on 19 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Pt recvd vax 4NOV92 & 5NOV92 & devel h/a, intermittent diarrhea, cough, muscular neck pain & malaise; No further details were provided;
Employee complaining of feeling cold and clammy, dull pain mid chest, fatigued and later told ER MD that he had temp 101 over the previous weekend on 2/25/17.
Warm, swollen size of tennis ball per mom Rt arm at VARIVAX injection site.
Information has been received from a health professional concerning three patients who on unknown dates were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patients experienced an adverse event. At the time of this report, the patient's outcomes were unknown. Additional information has been requested.
No additional AE reported; Caller is a medical assistant calling to report that an expired dose of PNEUMOVAX 23 was administered to a patient on 21JUN2022. Caller reports that the dose of PNEUMOVAX 23 expired on 8MAY2022 and did not experience a temperautre excursion through t; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.  On 21-JUN-2022, the patient was vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 ml, lot #T032003, expiration date: 08-MAY-2022 (vaccination schedule, anatomical location and route of administration were not provided) for prophylaxis (Expired product administered). The reporter stated the vaccine did not experience a temperature excursion through the date of administration. No additional adverse event was reported.
Felt ill after injections (within minutes). He continued to be ill next day.  He presented to hospital ER in respiratory failure - he was intubated. Rhabdomyolysis, acute renal failure, fever unconscious.
Swollen lymph nodes/ She notices it under right side of jaw; no sore throat but I can feel it ache; the first shot made my immune system weak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient (unknown if pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 18Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "PCOS" (unspecified if ongoing); "hypothyroidism" (ongoing); "gluten allergy" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "unknown", described as "Swollen lymph nodes/ She notices it under right side of jaw"; OROPHARYNGEAL PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "no sore throat but I can feel it ache"; IMMUNE SYSTEM DISORDER (non-serious) with onset 2021, outcome "unknown", described as "the first shot made my immune system weak".  No follow-up attempts are possible. No further information is expected.
Dizziness 5 minutes after the shot. Blurred vision, symptoms last for 3-4 minutes.
1. Itchy rash on inner aspect of both arms (2 wks after shot). Lasts 1-2 hrs. Takes Benadryl. It has appeared about 4 times since then on abdomen, chest, back, neck. 2. Swelling left side of neck (6 wks after shot). Took Benadryl. Lasted 45 min. It happened 6 wks later in the same place, was very hard, lasted 45 minutes. 3. Trouble swallowing (2.5 mos ago), lasted 30 minutes (took Benadryl).
slightly lack of energy.; Sore arm; a little tired; Stuffy head; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0150), via unspecified route of administration in the left arm on 02Apr2021 at 11:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation.  Medical history was reported as none and the patient had a history of allergy to amoxicillin. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6202), via unspecified route of administration in the left arm on 09Mar2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, the patient experienced sore arm, a little tired and stuffy head. On 03Apr2021, on 2nd day after the shot the patient experienced slightly lack of energy and sore arm continued.  The 3rd day after the shot only sore arm was there.  Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events reported. The clinical outcome of the event sore arm was not recovered while the outcome of events stuffy head, a little tired and lack of energy was recovered on 04Apr2021.   No follow-up attempts are needed. No further information is expected.